Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KF3O
|
|||
| Former ID |
DIB016234
|
|||
| Drug Name |
CardioPET
|
|||
| Indication | Coronary artery disease [ICD-11: BA80; ICD-10: I25.1, I25.4] | Phase 2 | [1] | |
| Company |
Fluoropharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H33FO2
|
|||
| Canonical SMILES |
CCCCCCCCC(CCCCC1CC1CC(=O)O)F
|
|||
| InChI |
1S/C18H33FO2/c1-2-3-4-5-6-7-11-17(19)12-9-8-10-15-13-16(15)14-18(20)21/h15-17H,2-14H2,1H3,(H,20,21)/t15-,16+,17?/m1/s1/i19-1
|
|||
| InChIKey |
DDTRZLZETKPBPQ-YWWFHXEUSA-N
|
|||
| CAS Number |
CAS 855927-17-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01826773) CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.